ATLANTA--(BUSINESS WIRE)--MIV Therapeutics Inc. (OTCBB:MIVT) (FWB:MIV), a leading developer of next-generation biocompatible coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices, announced that the Company has completed the acquisition of Biosync Scientific, an India-based designer and developer of innovative interventional cardiology products, including cardiovascular stents.
